간행물

생화학분자생물학회입니다.


BMB Reports

Emerging paradigms in cancer cell plasticity

  • 작성자

    Hyun Woo Park
  • 작성일자

    2024-07-22
  • 조회수

    874
Name: Hyun Woo Park ( hwp003@yonsei.ac.kr )
2016-PresentAssociate Professor, Department of Biochemistry, Yonsei University, Seoul
2012-2016Postdoctoral Fellow, Department of Pharmacology
University of California San Diego
2006-2010Ph.D., Department of Pharmacology, Yonsei University College of Medicine, Seoul

Emerging paradigms in cancer cell plasticity

Cancer cells metastasize to distant organs by altering their characteristics within the tumor microenvironment (TME) to effectively overcome challenges during the multistep tumorigenesis. Plasticity endows cancer cell with the capacity to shift between different states to invade, disseminate, and seed metastasis. The epithelial-to-mesenchymal transition (EMT) is a cellular program that abrogates cell-cell adhesions by EMT transcription factors (TF) and acquires mesenchymal features during cancer progression. On the other hand, adherent-to-suspension transition (AST) is an emerging theory that describes the acquisition of hematopoietic features by AST-TFs that can induce the reprogramming of anchorage dependency and promote cancer cell dissemination. The induction and plasticity of EMT and AST dynamically reprogram cell-cell and cell-matrix interaction during cancer dissemination and colonization. Here, we review the mechanisms governing cellular plasticity of AST and EMT during the metastatic cascade and discuss therapeutic challenges posed by these two morphological adaptations to provide insights for establishing new therapeutic interventions.


BMB Rep. 2024 Jun;57(6):273-280. doi: 10.5483/BMBRep.2024-0018
https://pubmed.ncbi.nlm.nih.gov/38627950/